SEER Inquiry System - Question 20031207 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 01/13/2025 6:36 AM

Question 20031207

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

#1: SEER PCM, 3rd Ed, Rev 1, 138b. January 2003

#2: Abs & Coding Guide Hem Dis, iv, 46. May 2002

Question:

Hormone Therapy--Hematopoietic, NOS: Is hormonal therapy coded for myelodysplastic syndrome, NOS? See Description.

Discussion:

Patient with myelodysplastic syndrome refused chemotherapy and was treated with high dose steroids. Patient also received Rituxan.

Answer:

Hormones, such as glucocorticoids and androgens, are generally of little if any benefit to patients with myelodysplastic syndrome, according to the NCI PDQ. Do not code steroids as treatment in the example above.

Cancer Site Category:

N/A

Data Item Category:

First course treatment

Other Category:

N/A

Year:

2003